Show simple item record

dc.contributor.authorAboy, Men
dc.contributor.authorLiddell, Kathleenen
dc.contributor.authorLiddicoat, Johnen
dc.contributor.authorCrespo, Cen
dc.date.accessioned2016-12-12T13:46:41Z
dc.date.available2016-12-12T13:46:41Z
dc.date.issued2016-11en
dc.identifier.issn1087-0156
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/261527
dc.description.abstractThree years later, the landmark $\textit{Myriad}$ decision on gene patents has led to some striking and unforeseen implications.
dc.languageENGen
dc.language.isoenen
dc.publisherNature Publishing Group
dc.title$\textit{Myriad's}$ impact on gene patentsen
dc.typeArticle
prism.endingPage1123
prism.issueIdentifier11en
prism.publicationDate2016en
prism.publicationNameNature Biotechnologyen
prism.startingPage1119
prism.volume34en
dc.identifier.doi10.17863/CAM.6723
dcterms.dateAccepted2016-10-05en
rioxxterms.versionofrecord10.1038/nbt.3719en
rioxxterms.versionAMen
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2016-11en
dc.contributor.orcidLiddicoat, John [0000-0001-7370-3936]
dc.identifier.eissn1546-1696
rioxxterms.typeJournal Article/Reviewen
cam.issuedOnline2016-11-08en
rioxxterms.freetoread.startdate2017-05-08


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record